nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulpiride—DRD3—bipolar disorder	0.494	0.591	CbGaD
Sulpiride—DRD2—bipolar disorder	0.342	0.409	CbGaD
Sulpiride—CA6—saliva—bipolar disorder	0.0168	0.293	CbGeAlD
Sulpiride—DRD3—telencephalic ventricle—bipolar disorder	0.0132	0.23	CbGeAlD
Sulpiride—DRD2—telencephalic ventricle—bipolar disorder	0.00558	0.0973	CbGeAlD
Sulpiride—CA2—blood plasma—bipolar disorder	0.00252	0.0439	CbGeAlD
Sulpiride—BCHE—blood plasma—bipolar disorder	0.00241	0.0421	CbGeAlD
Sulpiride—DRD3—nervous system—bipolar disorder	0.00187	0.0326	CbGeAlD
Sulpiride—Alizapride—DRD2—bipolar disorder	0.00187	0.204	CrCbGaD
Sulpiride—CA9—cerebellum—bipolar disorder	0.00186	0.0323	CbGeAlD
Sulpiride—Remoxipride—DRD4—bipolar disorder	0.00153	0.167	CrCbGaD
Sulpiride—CA12—nervous system—bipolar disorder	0.00146	0.0254	CbGeAlD
Sulpiride—DRD3—brain—bipolar disorder	0.00143	0.0249	CbGeAlD
Sulpiride—Remoxipride—DRD3—bipolar disorder	0.00132	0.144	CrCbGaD
Sulpiride—CA2—adrenal cortex—bipolar disorder	0.00128	0.0223	CbGeAlD
Sulpiride—Amisulpride—DRD3—bipolar disorder	0.00126	0.138	CrCbGaD
Sulpiride—CA12—brain—bipolar disorder	0.00112	0.0194	CbGeAlD
Sulpiride—Remoxipride—DRD2—bipolar disorder	0.000913	0.0997	CrCbGaD
Sulpiride—CA2—thyroid gland—bipolar disorder	0.000891	0.0155	CbGeAlD
Sulpiride—Amisulpride—DRD2—bipolar disorder	0.000875	0.0956	CrCbGaD
Sulpiride—BCHE—thyroid gland—bipolar disorder	0.000854	0.0149	CbGeAlD
Sulpiride—DRD2—nervous system—bipolar disorder	0.000792	0.0138	CbGeAlD
Sulpiride—CA2—nervous system—bipolar disorder	0.000749	0.0131	CbGeAlD
Sulpiride—DRD2—cerebellum—bipolar disorder	0.000745	0.013	CbGeAlD
Sulpiride—BCHE—nervous system—bipolar disorder	0.000718	0.0125	CbGeAlD
Sulpiride—Remoxipride—HTR2A—bipolar disorder	0.000706	0.0771	CrCbGaD
Sulpiride—CA2—cerebellum—bipolar disorder	0.000705	0.0123	CbGeAlD
Sulpiride—Amisulpride—HTR2A—bipolar disorder	0.000676	0.0739	CrCbGaD
Sulpiride—BCHE—cerebellum—bipolar disorder	0.000676	0.0118	CbGeAlD
Sulpiride—DRD2—brain—bipolar disorder	0.000605	0.0105	CbGeAlD
Sulpiride—CA2—brain—bipolar disorder	0.000573	0.00998	CbGeAlD
Sulpiride—BCHE—brain—bipolar disorder	0.000549	0.00956	CbGeAlD
Sulpiride—DRD3—GPCR ligand binding—TSHB—bipolar disorder	0.000122	0.00125	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—SLC6A3—bipolar disorder	0.000121	0.00124	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—ADCY2—bipolar disorder	0.000121	0.00123	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00012	0.00123	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—DRD3—bipolar disorder	0.000119	0.00122	CbGpPWpGaD
Sulpiride—CA12—Metabolism—TSHB—bipolar disorder	0.000119	0.00122	CbGpPWpGaD
Sulpiride—CA12—Metabolism—TPH2—bipolar disorder	0.000119	0.00122	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CACNB2—bipolar disorder	0.000119	0.00122	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.000118	0.00121	CbGpPWpGaD
Sulpiride—CA12—Metabolism—DPYD—bipolar disorder	0.000117	0.0012	CbGpPWpGaD
Sulpiride—CA9—Metabolism—NR1D1—bipolar disorder	0.000116	0.00119	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—DRD4—bipolar disorder	0.000116	0.00118	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.000114	0.00117	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.000114	0.00117	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.000112	0.00115	CbGpPWpGaD
Sulpiride—CA9—Metabolism—NCAN—bipolar disorder	0.000111	0.00114	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.000111	0.00113	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—NTRK1—bipolar disorder	0.000111	0.00113	CbGpPWpGaD
Sulpiride—CA6—Metabolism—SNAP25—bipolar disorder	0.00011	0.00112	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—ADCY2—bipolar disorder	0.000109	0.00111	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CACNA1C—bipolar disorder	0.000109	0.00111	CbGpPWpGaD
Sulpiride—CA9—Metabolism—SLC5A3—bipolar disorder	0.000109	0.00111	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.000107	0.0011	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—DGKH—bipolar disorder	0.000107	0.00109	CbGpPWpGaD
Sulpiride—CA12—Metabolism—PIK3C2A—bipolar disorder	0.000106	0.00108	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—COMT—bipolar disorder	0.000103	0.00106	CbGpPWpGaD
Sulpiride—BCHE—Neuronal System—MAOA—bipolar disorder	0.000103	0.00105	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.000101	0.00104	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—HTR1A—bipolar disorder	0.000101	0.00103	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	9.99e-05	0.00102	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—TAC1—bipolar disorder	9.94e-05	0.00102	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	9.89e-05	0.00101	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	9.8e-05	0.001	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	9.8e-05	0.001	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—DRD5—bipolar disorder	9.78e-05	0.001	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—HTR2C—bipolar disorder	9.75e-05	0.000997	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—DRD1—bipolar disorder	9.75e-05	0.000997	CbGpPWpGaD
Sulpiride—CA6—Metabolism—ADCY2—bipolar disorder	9.73e-05	0.000995	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—DGKH—bipolar disorder	9.71e-05	0.000993	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—RGS4—bipolar disorder	9.59e-05	0.000981	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—ADM—bipolar disorder	9.57e-05	0.000979	CbGpPWpGaD
Sulpiride—CA12—Metabolism—SNAP25—bipolar disorder	9.51e-05	0.000972	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	9.49e-05	0.00097	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—TSHB—bipolar disorder	9.33e-05	0.000954	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—TACR1—bipolar disorder	9.33e-05	0.000954	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CLOCK—bipolar disorder	9.33e-05	0.000954	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	9.21e-05	0.000942	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	9.17e-05	0.000937	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—DRD4—bipolar disorder	9.16e-05	0.000937	CbGpPWpGaD
Sulpiride—CA2—Metabolism—TPH2—bipolar disorder	9.09e-05	0.00093	CbGpPWpGaD
Sulpiride—CA2—Metabolism—TSHB—bipolar disorder	9.09e-05	0.00093	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CACNB2—bipolar disorder	9.09e-05	0.00093	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—GSK3B—bipolar disorder	9.01e-05	0.000921	CbGpPWpGaD
Sulpiride—CA2—Metabolism—DPYD—bipolar disorder	8.95e-05	0.000915	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—DRD5—bipolar disorder	8.88e-05	0.000908	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—IMPA1—bipolar disorder	8.79e-05	0.000898	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—RGS4—bipolar disorder	8.71e-05	0.00089	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	8.59e-05	0.000878	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—DRD2—bipolar disorder	8.54e-05	0.000873	CbGpPWpGaD
Sulpiride—CA12—Metabolism—ADCY2—bipolar disorder	8.41e-05	0.00086	CbGpPWpGaD
Sulpiride—CA6—Metabolism—COMT—bipolar disorder	8.33e-05	0.000852	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—TSHB—bipolar disorder	8.33e-05	0.000851	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CACNA1C—bipolar disorder	8.32e-05	0.00085	CbGpPWpGaD
Sulpiride—CA6—Metabolism—MAOA—bipolar disorder	8.27e-05	0.000846	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—DGKH—bipolar disorder	8.18e-05	0.000837	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PIK3C2A—bipolar disorder	8.1e-05	0.000829	CbGpPWpGaD
Sulpiride—DRD3—G alpha (i) signalling events—POMC—bipolar disorder	7.89e-05	0.000806	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CLOCK—bipolar disorder	7.86e-05	0.000804	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	7.85e-05	0.000803	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—HTR1A—bipolar disorder	7.72e-05	0.00079	CbGpPWpGaD
Sulpiride—CA9—Metabolism—TSHB—bipolar disorder	7.66e-05	0.000783	CbGpPWpGaD
Sulpiride—CA9—Metabolism—TPH2—bipolar disorder	7.66e-05	0.000783	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CACNB2—bipolar disorder	7.66e-05	0.000783	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—TAC1—bipolar disorder	7.61e-05	0.000778	CbGpPWpGaD
Sulpiride—CA9—Metabolism—DPYD—bipolar disorder	7.54e-05	0.000771	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—DRD5—bipolar disorder	7.48e-05	0.000765	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—NDUFV2—bipolar disorder	7.47e-05	0.000764	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—DRD1—bipolar disorder	7.46e-05	0.000763	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—HTR2C—bipolar disorder	7.46e-05	0.000763	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—DGKH—bipolar disorder	7.43e-05	0.00076	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—TRPC3—bipolar disorder	7.41e-05	0.000758	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—RGS4—bipolar disorder	7.34e-05	0.00075	CbGpPWpGaD
Sulpiride—CA2—Metabolism—SNAP25—bipolar disorder	7.27e-05	0.000743	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—AKR1C4—bipolar disorder	7.24e-05	0.00074	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—DRD3—bipolar disorder	7.22e-05	0.000739	CbGpPWpGaD
Sulpiride—CA12—Metabolism—COMT—bipolar disorder	7.21e-05	0.000737	CbGpPWpGaD
Sulpiride—CA12—Metabolism—MAOA—bipolar disorder	7.15e-05	0.000731	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—ADM—bipolar disorder	7.07e-05	0.000723	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	7.01e-05	0.000717	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—DRD4—bipolar disorder	7.01e-05	0.000717	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CACNA1C—bipolar disorder	7.01e-05	0.000717	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—GSK3B—bipolar disorder	6.89e-05	0.000705	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—PDE4B—bipolar disorder	6.89e-05	0.000705	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—TSHB—bipolar disorder	6.89e-05	0.000705	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—TACR1—bipolar disorder	6.89e-05	0.000705	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PIK3C2A—bipolar disorder	6.83e-05	0.000698	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—DRD5—bipolar disorder	6.8e-05	0.000695	CbGpPWpGaD
Sulpiride—CA6—Metabolism—MTHFR—bipolar disorder	6.73e-05	0.000688	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—TRPC3—bipolar disorder	6.73e-05	0.000688	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—RGS4—bipolar disorder	6.66e-05	0.000681	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—NR1D1—bipolar disorder	6.5e-05	0.000665	CbGpPWpGaD
Sulpiride—CA2—Metabolism—ADCY2—bipolar disorder	6.43e-05	0.000658	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—ADM—bipolar disorder	6.42e-05	0.000656	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—GSK3A—bipolar disorder	6.42e-05	0.000656	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	6.27e-05	0.000641	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—TSHB—bipolar disorder	6.26e-05	0.00064	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PDE4B—bipolar disorder	6.26e-05	0.00064	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—TACR1—bipolar disorder	6.26e-05	0.00064	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—AKR1C4—bipolar disorder	6.23e-05	0.000637	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—NCAN—bipolar disorder	6.22e-05	0.000636	CbGpPWpGaD
Sulpiride—CA9—Metabolism—SNAP25—bipolar disorder	6.13e-05	0.000626	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SLC5A3—bipolar disorder	6.09e-05	0.000623	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—POMC—bipolar disorder	6.04e-05	0.000617	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	6.01e-05	0.000614	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—HTR2A—bipolar disorder	5.98e-05	0.000611	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—TCF7L2—bipolar disorder	5.87e-05	0.0006	CbGpPWpGaD
Sulpiride—CA12—Metabolism—MTHFR—bipolar disorder	5.82e-05	0.000595	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—DGKH—bipolar disorder	5.74e-05	0.000586	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—HTR1A—bipolar disorder	5.7e-05	0.000583	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—TRPC3—bipolar disorder	5.67e-05	0.00058	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—TAC1—bipolar disorder	5.62e-05	0.000574	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—DRD1—bipolar disorder	5.51e-05	0.000563	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—HTR2C—bipolar disorder	5.51e-05	0.000563	CbGpPWpGaD
Sulpiride—CA2—Metabolism—COMT—bipolar disorder	5.51e-05	0.000563	CbGpPWpGaD
Sulpiride—CA2—Metabolism—MAOA—bipolar disorder	5.47e-05	0.000559	CbGpPWpGaD
Sulpiride—CA9—Metabolism—ADCY2—bipolar disorder	5.42e-05	0.000554	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—ADM—bipolar disorder	5.41e-05	0.000553	CbGpPWpGaD
Sulpiride—CA6—Metabolism—POMC—bipolar disorder	5.39e-05	0.000551	CbGpPWpGaD
Sulpiride—CA6—Metabolism—INS—bipolar disorder	5.36e-05	0.000548	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—TSHB—bipolar disorder	5.27e-05	0.000539	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—TACR1—bipolar disorder	5.27e-05	0.000539	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—PDE4B—bipolar disorder	5.27e-05	0.000539	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—DRD5—bipolar disorder	5.25e-05	0.000536	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—HTR1A—bipolar disorder	5.18e-05	0.00053	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—DRD4—bipolar disorder	5.18e-05	0.00053	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—TRPC3—bipolar disorder	5.15e-05	0.000527	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—RGS4—bipolar disorder	5.15e-05	0.000526	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—TAC1—bipolar disorder	5.1e-05	0.000522	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—HTR2C—bipolar disorder	5e-05	0.000511	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—DRD1—bipolar disorder	5e-05	0.000511	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ADM—bipolar disorder	4.91e-05	0.000502	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—ADCY2—bipolar disorder	4.88e-05	0.000498	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—DRD2—bipolar disorder	4.82e-05	0.000493	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	4.8e-05	0.000491	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—TSHB—bipolar disorder	4.79e-05	0.00049	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—TACR1—bipolar disorder	4.79e-05	0.00049	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PDE4B—bipolar disorder	4.79e-05	0.00049	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—POMC—bipolar disorder	4.78e-05	0.000488	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—AKR1C4—bipolar disorder	4.77e-05	0.000488	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—DRD4—bipolar disorder	4.7e-05	0.000481	CbGpPWpGaD
Sulpiride—CA12—Metabolism—POMC—bipolar disorder	4.66e-05	0.000476	CbGpPWpGaD
Sulpiride—CA9—Metabolism—COMT—bipolar disorder	4.64e-05	0.000475	CbGpPWpGaD
Sulpiride—CA12—Metabolism—INS—bipolar disorder	4.63e-05	0.000474	CbGpPWpGaD
Sulpiride—CA9—Metabolism—MAOA—bipolar disorder	4.61e-05	0.000471	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—HTR2A—bipolar disorder	4.58e-05	0.000468	CbGpPWpGaD
Sulpiride—CA2—Metabolism—MTHFR—bipolar disorder	4.45e-05	0.000455	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—ADCY2—bipolar disorder	4.43e-05	0.000453	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CLOCK—bipolar disorder	4.4e-05	0.00045	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—DGKH—bipolar disorder	4.39e-05	0.000449	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—DRD2—bipolar disorder	4.38e-05	0.000448	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—HTR1A—bipolar disorder	4.36e-05	0.000446	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—TAC1—bipolar disorder	4.3e-05	0.000439	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—TSHB—bipolar disorder	4.29e-05	0.000439	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—TPH2—bipolar disorder	4.29e-05	0.000439	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CACNB2—bipolar disorder	4.29e-05	0.000439	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—DPYD—bipolar disorder	4.22e-05	0.000432	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—DRD1—bipolar disorder	4.22e-05	0.000431	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—HTR2C—bipolar disorder	4.22e-05	0.000431	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—DRD3—bipolar disorder	4.08e-05	0.000417	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—DRD5—bipolar disorder	4.01e-05	0.00041	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TRPC3—bipolar disorder	3.98e-05	0.000407	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—HTR1A—bipolar disorder	3.96e-05	0.000405	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—DRD4—bipolar disorder	3.96e-05	0.000405	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—RGS4—bipolar disorder	3.94e-05	0.000403	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CACNA1C—bipolar disorder	3.93e-05	0.000401	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—TAC1—bipolar disorder	3.9e-05	0.000399	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—HTR2C—bipolar disorder	3.83e-05	0.000391	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—DRD1—bipolar disorder	3.83e-05	0.000391	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PIK3C2A—bipolar disorder	3.83e-05	0.000391	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADM—bipolar disorder	3.79e-05	0.000388	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	3.77e-05	0.000386	CbGpPWpGaD
Sulpiride—CA9—Metabolism—MTHFR—bipolar disorder	3.75e-05	0.000384	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—ADCY2—bipolar disorder	3.73e-05	0.000381	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—DRD3—bipolar disorder	3.71e-05	0.000379	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PDE4B—bipolar disorder	3.7e-05	0.000378	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TSHB—bipolar disorder	3.7e-05	0.000378	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TACR1—bipolar disorder	3.7e-05	0.000378	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—POMC—bipolar disorder	3.65e-05	0.000374	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—DRD4—bipolar disorder	3.6e-05	0.000368	CbGpPWpGaD
Sulpiride—CA2—Metabolism—POMC—bipolar disorder	3.56e-05	0.000364	CbGpPWpGaD
Sulpiride—CA2—Metabolism—INS—bipolar disorder	3.54e-05	0.000362	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SNAP25—bipolar disorder	3.43e-05	0.000351	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ADCY2—bipolar disorder	3.39e-05	0.000346	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—HTR2A—bipolar disorder	3.38e-05	0.000345	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—POMC—bipolar disorder	3.26e-05	0.000333	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—INS—bipolar disorder	3.24e-05	0.000332	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—HTR2A—bipolar disorder	3.07e-05	0.000314	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HTR1A—bipolar disorder	3.06e-05	0.000313	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TRPC3—bipolar disorder	3.04e-05	0.000311	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ADCY2—bipolar disorder	3.04e-05	0.00031	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TAC1—bipolar disorder	3.01e-05	0.000308	CbGpPWpGaD
Sulpiride—CA9—Metabolism—POMC—bipolar disorder	3e-05	0.000307	CbGpPWpGaD
Sulpiride—CA9—Metabolism—INS—bipolar disorder	2.98e-05	0.000305	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HTR2C—bipolar disorder	2.96e-05	0.000302	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—DRD1—bipolar disorder	2.96e-05	0.000302	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADM—bipolar disorder	2.9e-05	0.000297	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NTRK2—bipolar disorder	2.87e-05	0.000294	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GSK3A—bipolar disorder	2.85e-05	0.000291	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TSHB—bipolar disorder	2.83e-05	0.000289	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PDE4B—bipolar disorder	2.83e-05	0.000289	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TACR1—bipolar disorder	2.83e-05	0.000289	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—DRD4—bipolar disorder	2.78e-05	0.000284	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—POMC—bipolar disorder	2.7e-05	0.000276	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADCY2—bipolar disorder	2.62e-05	0.000267	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TCF7L2—bipolar disorder	2.61e-05	0.000266	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—COMT—bipolar disorder	2.6e-05	0.000266	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—DRD2—bipolar disorder	2.59e-05	0.000265	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—HTR2A—bipolar disorder	2.59e-05	0.000264	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—MAOA—bipolar disorder	2.58e-05	0.000264	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—POMC—bipolar disorder	2.45e-05	0.000251	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—HTR2A—bipolar disorder	2.35e-05	0.00024	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NTRK1—bipolar disorder	2.34e-05	0.00024	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HTR1A—bipolar disorder	2.34e-05	0.000239	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TAC1—bipolar disorder	2.31e-05	0.000236	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—S100B—bipolar disorder	2.28e-05	0.000233	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HTR2C—bipolar disorder	2.26e-05	0.000231	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—DRD1—bipolar disorder	2.26e-05	0.000231	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NTRK2—bipolar disorder	2.2e-05	0.000225	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—DRD3—bipolar disorder	2.19e-05	0.000224	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GSK3A—bipolar disorder	2.18e-05	0.000223	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—DRD4—bipolar disorder	2.13e-05	0.000217	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—MTHFR—bipolar disorder	2.1e-05	0.000215	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—POMC—bipolar disorder	2.07e-05	0.000211	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NRG1—bipolar disorder	2.01e-05	0.000206	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADCY2—bipolar disorder	2e-05	0.000205	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	1.99e-05	0.000204	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—POMC—bipolar disorder	1.88e-05	0.000192	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HTR2A—bipolar disorder	1.81e-05	0.000185	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NTRK1—bipolar disorder	1.79e-05	0.000183	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—S100B—bipolar disorder	1.74e-05	0.000178	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—POMC—bipolar disorder	1.68e-05	0.000172	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—INS—bipolar disorder	1.67e-05	0.000171	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NRG1—bipolar disorder	1.54e-05	0.000157	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GSK3B—bipolar disorder	1.46e-05	0.000149	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—POMC—bipolar disorder	1.45e-05	0.000148	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—INS—bipolar disorder	1.44e-05	0.000147	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HTR2A—bipolar disorder	1.39e-05	0.000142	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GSK3B—bipolar disorder	1.12e-05	0.000114	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—POMC—bipolar disorder	1.11e-05	0.000113	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—INS—bipolar disorder	1.1e-05	0.000113	CbGpPWpGaD
